iCAD, Inc. – NASDAQ:ICAD

iCAD stock price today

$3.87
+1.92
+98.46%
Financial Health
0
1
2
3
4
5
6
7
8
9

iCAD stock price monthly change

+50.00%
month

iCAD stock price quarterly change

+50.00%
quarter

iCAD stock price yearly change

+3.72%
year

iCAD key metrics

Market Cap
46.97M
Enterprise value
N/A
P/E
-2.6
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
1.28
Price/Book
1.03
PEG ratio
0.06
EPS
-0.11
Revenue
19.63M
EBITDA
-4.58M
Income
-2.98M
Revenue Q/Q
-14.26%
Revenue Y/Y
-25.05%
Profit margin
-49.29%
Oper. margin
-49.85%
Gross margin
70.9%
EBIT margin
-49.85%
EBITDA margin
-23.35%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

iCAD stock price history

iCAD stock forecast

iCAD financial statements

iCAD, Inc. (NASDAQ:ICAD): Profit margin
Jun 2023 5.86M -1.75M -29.84%
Sep 2023 4.07M -1.37M -33.73%
Dec 2023 4.74M 1.36M 28.73%
Mar 2024 4.95M -1.22M -24.67%
iCAD, Inc. (NASDAQ:ICAD): Analyst Estimates
Sep 2025 5.06M -1.60M -31.62%
Oct 2025 5.06M -1.55M -30.73%
Dec 2025 5.46M -1.43M -26.26%
Mar 2026 5.38M -1.08M -20.2%
  • Analysts Price target

  • Financials & Ratios estimates

iCAD, Inc. (NASDAQ:ICAD): Debt to assets
Jun 2023 44832000 14.65M 32.7%
Sep 2023 45828000 14.79M 32.28%
Dec 2023 41418000 8.00M 19.32%
Mar 2024 40395000 7.93M 19.64%
iCAD, Inc. (NASDAQ:ICAD): Cash Flow
Jun 2023 -405K -221K 46K
Sep 2023 -1.58M -332K 1.92M
Dec 2023 -1.45M 3.95M 125K
Mar 2024 -1.18M -206K 0

iCAD alternative data

iCAD, Inc. (NASDAQ:ICAD): Employee count
Aug 2023 108
Sep 2023 108
Oct 2023 108
Nov 2023 108
Dec 2023 108
Jan 2024 108
Feb 2024 108
Mar 2024 108
Apr 2024 108
May 2024 67
Jun 2024 67
Jul 2024 67

iCAD other data

10.99% -26.57%
of ICAD is owned by hedge funds
2.76M -6.69M
shares is hold by hedge funds

iCAD, Inc. (NASDAQ:ICAD): Insider trades (number of shares)
Period Buy Sel
Sep 2022 0 38960
Mar 2023 40000 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
BROWN DANA R director, officer: See Remarks
Common Stock 40,000 $1.3 $52,000
Option
GO JONATHAN officer: Chief Te.. Employee Stock Option (Right to Buy) 45,000 $2.27 $102,150
Sale
GO JONATHAN officer: Chief Te.. Common Stock 1,080 $2.65 $2,862
Sale
GO JONATHAN officer: Chief Te.. Common Stock 37,880 $2.74 $103,791
Option
GO JONATHAN officer: Chief Te.. Common Stock 45,000 $2.27 $102,150
Option
GO JONATHAN officer: Chief Te.. Employee Stock Option (Right to Buy) 20,000 $2.9 $58,000
Purchase
IRISH TIMOTHY NORRIS director
Common Stock 5,500 $4.63 $25,465
Sale
SASSINE ANDY director
Common Stock 10,000 $5.49 $54,900
Sale
SASSINE ANDY director
Common Stock 10,000 $5.26 $52,600
Option
GO JONATHAN officer: Chief Te.. Common Stock 20,000 $2.9 $58,000
Patent
Application
Filling date: 22 Nov 2019 Issue date: 28 May 2020
Grant
Filling date: 1 Apr 2015 Issue date: 15 Oct 2019
Grant
Filling date: 10 Nov 2014 Issue date: 13 Aug 2019
Wednesday, 11 December 2024
globenewswire.com
Wednesday, 4 December 2024
globenewswire.com
Tuesday, 26 November 2024
globenewswire.com
Wednesday, 13 November 2024
seekingalpha.com
globenewswire.com
Wednesday, 6 November 2024
globenewswire.com
Wednesday, 16 October 2024
newsfilecorp.com
Thursday, 3 October 2024
globenewswire.com
Tuesday, 13 August 2024
seekingalpha.com
globenewswire.com
Monday, 29 July 2024
globenewswire.com
Wednesday, 26 June 2024
globenewswire.com
Tuesday, 4 June 2024
globenewswire.com
Friday, 17 May 2024
investorplace.com
Wednesday, 15 May 2024
globenewswire.com
Wednesday, 8 May 2024
GlobeNewsWire
Thursday, 14 March 2024
InvestorPlace
Tuesday, 12 March 2024
Seeking Alpha
Friday, 1 March 2024
InvestorPlace
Tuesday, 27 February 2024
GlobeNewsWire
Wednesday, 22 November 2023
InvestorPlace
Monday, 13 November 2023
Seeking Alpha
Monday, 30 October 2023
GlobeNewsWire
Sunday, 8 October 2023
InvestorPlace
Friday, 1 September 2023
InvestorPlace
Monday, 14 August 2023
Seeking Alpha
Monday, 7 August 2023
InvestorPlace
Monday, 31 July 2023
GlobeNewsWire
Tuesday, 25 July 2023
InvestorPlace
Friday, 7 July 2023
InvestorPlace
  • What's the price of iCAD stock today?

    One share of iCAD stock can currently be purchased for approximately $3.87.

  • When is iCAD's next earnings date?

    Unfortunately, iCAD's (ICAD) next earnings date is currently unknown.

  • Does iCAD pay dividends?

    No, iCAD does not pay dividends.

  • How much money does iCAD make?

    iCAD has a market capitalization of 46.97M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 38.03% to 17.32M US dollars.

  • What is iCAD's stock symbol?

    iCAD, Inc. is traded on the NASDAQ under the ticker symbol "ICAD".

  • What is iCAD's primary industry?

    Company operates in the Healthcare sector and Medical - Devices industry.

  • How do i buy shares of iCAD?

    Shares of iCAD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are iCAD's key executives?

    iCAD's management team includes the following people:

    • Mr. Michael S. Klein Executive Chairman & Chief Executive Officer(age: 71, pay: $621,020)
    • Ms. Stacey M. Stevens Pres(age: 57, pay: $484,830)
    • Mr. Jonathan Go Chief Technology Officer(age: 62, pay: $416,340)
  • How many employees does iCAD have?

    As Jul 2024, iCAD employs 67 workers, which is 38% less then previous quarter.

  • When iCAD went public?

    iCAD, Inc. is publicly traded company for more then 40 years since IPO on 13 Dec 1984.

  • What is iCAD's official website?

    The official website for iCAD is icadmed.com.

  • Where are iCAD's headquarters?

    iCAD is headquartered at 98 Spit Brook Road, Nashua, NH.

  • How can i contact iCAD?

    iCAD's mailing address is 98 Spit Brook Road, Nashua, NH and company can be reached via phone at +60 38825200.

iCAD company profile:

iCAD, Inc.

icadmed.com
Exchange:

NASDAQ

Full time employees:

67

Industry:

Medical - Devices

Sector:

Healthcare

iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, and image storage and review systems; SecondLook, a machine learning-based cancer detection algorithm that analyzes 2D full-field digital mammography images to identify and mark suspicious masses and calcifications; and automated density assessment solutions, which provides automated, consistent, and standardized density assessment. It also offers ProFound AI, a deep-learning algorithm designed to detect malignant soft-tissue densities and calcifications in digital breast tomosynthesis; ProFound AI Risk, a tool that provides breast cancer risk estimation based on a screening mammogram; and magnetic resonance imaging applications, a tool to detect breast and prostate cancer. In addition, the company offers VeraLook, a solution designed to support the detection of colonic polyps in conjunction with CT Colonography. Further, it provides Xoft Axxent electronic brachytherapy systems for the treatment of early stage breast, non-melanoma skin, and gynecological cancers to university research and community hospitals, cancer care clinics, veterinary facilities, and dermatology offices. The company sells its products through direct sales organizations, as well as through various original equipment manufacturer partners, distributors, technology platform partners, and resellers. It also exports its products in Europe, Taiwan, Canada, China, and internationally. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.

98 Spit Brook Road
Nashua, NH 03062

CIK: 0000749660
ISIN: US44934S2068
CUSIP: 44934S206